G.M. Murphy

1.5k total citations
57 papers, 1.1k citations indexed

About

G.M. Murphy is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, G.M. Murphy has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in G.M. Murphy's work include Pediatric Hepatobiliary Diseases and Treatments (19 papers), Gallbladder and Bile Duct Disorders (15 papers) and Drug Transport and Resistance Mechanisms (10 papers). G.M. Murphy is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (19 papers), Gallbladder and Bile Duct Disorders (15 papers) and Drug Transport and Resistance Mechanisms (10 papers). G.M. Murphy collaborates with scholars based in United Kingdom, Ireland and Canada. G.M. Murphy's co-authors include R. H. Dowling, Paul N. Maton, G. E. Sladen, Philip Howard, Gillian Gibson, P Isaacs, Spiros D. Ladas, S. Vaja, J. H. Iser and Elaine W. Kay and has published in prestigious journals such as The Lancet, Gastroenterology and American Journal of Psychiatry.

In The Last Decade

G.M. Murphy

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.M. Murphy United Kingdom 20 374 337 295 246 214 57 1.1k
T S Low-Beer United Kingdom 20 414 1.1× 288 0.9× 240 0.8× 249 1.0× 31 0.1× 45 1.1k
Angelo Burlina Italy 16 303 0.8× 220 0.7× 192 0.7× 181 0.7× 20 0.1× 89 1.1k
Mitsuyoshi Utsugi Japan 22 125 0.3× 239 0.7× 379 1.3× 118 0.5× 30 0.1× 53 1.3k
Minoru Yagi Japan 16 404 1.1× 91 0.3× 225 0.8× 63 0.3× 14 0.1× 93 872
William K. Schubert United States 25 563 1.5× 207 0.6× 82 0.3× 308 1.3× 11 0.1× 68 2.0k
Paul Andersson Sweden 17 104 0.3× 62 0.2× 399 1.4× 122 0.5× 70 0.3× 30 1.1k
Haruki Mori Japan 14 265 0.7× 297 0.9× 155 0.5× 115 0.5× 10 0.0× 95 771
Fred Alexander United States 17 200 0.5× 125 0.4× 145 0.5× 70 0.3× 22 0.1× 47 880
Paul Rubin United States 18 193 0.5× 94 0.3× 622 2.1× 41 0.2× 77 0.4× 39 1.8k
Nobuhiko Ueda Japan 19 358 1.0× 440 1.3× 317 1.1× 119 0.5× 7 0.0× 162 1.2k

Countries citing papers authored by G.M. Murphy

Since Specialization
Citations

This map shows the geographic impact of G.M. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.M. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.M. Murphy more than expected).

Fields of papers citing papers by G.M. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.M. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.M. Murphy. The network helps show where G.M. Murphy may publish in the future.

Co-authorship network of co-authors of G.M. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of G.M. Murphy. A scholar is included among the top collaborators of G.M. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.M. Murphy. G.M. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Rosalind, et al.. (2009). Solar urticaria successfully treated with intravenous immunoglobulin. Clinical and Experimental Dermatology. 34(8). e660–e662. 18 indexed citations
2.
Lavin, Peter, Patrick O’Kelly, F.J. Moloney, et al.. (2007). Improved Renal Allograft Survival with Vitamin D Receptor Polymorphism. Renal Failure. 29(7). 785–789. 12 indexed citations
3.
Kovach, Bradley T., G.M. Murphy, Clark C. Otley, et al.. (2006). Oral Retinoids for Chemoprevention of Skin Cancers in Organ Transplant Recipients: Results of a Survey. Transplantation Proceedings. 38(5). 1366–1368. 12 indexed citations
4.
Murphy, G.M., et al.. (2003). Mycosis fungoides presenting as annular erythema. British Journal of Dermatology. 148(3). 591–591. 13 indexed citations
5.
Pereira, Stephen P., et al.. (2001). Octreotide increases the proportions of arachidonic acid‐rich phospholipids in gall‐bladder bile. Alimentary Pharmacology & Therapeutics. 15(9). 1435–1443. 5 indexed citations
6.
Demeule, Michel, et al.. (2000). Association of cyclophilin A with renal brush border membranes: Redistribution by cyclosporine A. Kidney International. 57(4). 1590–1598. 15 indexed citations
7.
Anstey, A.V., B. L. Diffey, Ray Jobling, et al.. (1999). Home phototherapy: report on a workshop of the British Photodermatology Group, December 1996. British Journal of Dermatology. 140(2). 195–199. 17 indexed citations
8.
Gibson, Gillian, A O’Grady, Elaine W. Kay, & G.M. Murphy. (1998). Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients.. PubMed. 10(1). 42–7. 21 indexed citations
9.
Murphy, G.M.. (1994). Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. Gut. 35(3). 430.2–430. 90 indexed citations
10.
Sant, S & G.M. Murphy. (1994). Neurotropic ulceration systemic sclerosis. Clinical and Experimental Dermatology. 19(1). 65–66. 2 indexed citations
11.
Buckley, AR, et al.. (1994). Allergic contact dermatitis from tioconazole without cross‐sensitivity to other imidazoles. Contact Dermatitis. 30(5). 308–308. 8 indexed citations
12.
Dowling, R. H., et al.. (1993). Gallstones during Octreotide Therapy. Digestion. 54(1). 107–120. 30 indexed citations
13.
Howard, Philip, G.M. Murphy, & R. H. Dowling. (1991). Gall bladder emptying patterns in response to a normal meal in healthy subjects and patients with gall stones: ultrasound study.. Gut. 32(11). 1406–1411. 62 indexed citations
14.
Stubbs, Andrew, G.M. Murphy, & Mark Wilkinson. (1991). Isocratic high-performance liquid chromatographic measurement of optimal 5α-steroid reductase activity in Hep-G2 cells. Journal of Chromatography B Biomedical Sciences and Applications. 570(2). 293–299. 3 indexed citations
15.
Rokkas, Theodoros, S. Vaja, G.M. Murphy, & R.H. Dowling. (1990). Aminoguanidine Blocks Intestinal Diamine Oxidase (DAO) Activity and Enhances the Intestinal Adaptive Response to Resection in the Rat. Digestion. 46(2). 447–457. 25 indexed citations
16.
Howard, Philip, et al.. (1989). Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.. Gut. 30(1). 97–103. 14 indexed citations
17.
Ladas, Spiros D., P Isaacs, G.M. Murphy, & G. E. Sladen. (1986). Fasting and postprandial ileal function in adapted ileostomates and normal subjects.. Gut. 27(8). 906–912. 26 indexed citations
18.
Ladas, Spiros D., P Isaacs, G.M. Murphy, & G. E. Sladen. (1984). Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man.. Gut. 25(4). 405–411. 52 indexed citations
19.
Maton, Paul N., G.M. Murphy, & R. H. Dowling. (1980). Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.. Gut. 21(12). 1082–1086. 13 indexed citations
20.
Williams, G., Lisa Mathews, N. Breuer, G.M. Murphy, & R. H. Dowling. (1980). Effect of Ursodeoxycholic Acid (UDCA) on Primary Bile Acid Kinetics in Gallstone Patients. Clinical Science. 58(2). 15P–15P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T S Low-Beer Breakdown of academic impact, for papers by Angelo Burlina Breakdown of academic impact, for papers by Mitsuyoshi Utsugi Breakdown of academic impact, for papers by Minoru Yagi Breakdown of academic impact, for papers by William K. Schubert Breakdown of academic impact, for papers by Paul Andersson Breakdown of academic impact, for papers by Haruki Mori Breakdown of academic impact, for papers by Fred Alexander Breakdown of academic impact, for papers by Paul Rubin Breakdown of academic impact, for papers by Nobuhiko Ueda
Rankless by CCL
2026